Innovative Medicines Initiative (IMI2) publishes 10th Call

Date: 
21.12.2016

IMI has now launched its 10th Call for proposals under IMI 2.

The Call includes the following topics:

  • Understanding hypoglycaemia: the underlying mechanisms and addressing clinical determinants as well as consequences for people with diabetes by combining databases from clinical trials
  • How big data could support better diagnosis and treatment outcomes for prostate cancer (part of the Big Data for Better Outcomes programme)
  • Improving the care of patients suffering from acute or chronic pain (this topic includes three subtopics on patient reported outcomes; biomarkers; and chronic pelvic pain)
  • Creation of a pan-European paediatric clinical trials network
  • Biomanufacturing 2020: development of innovative high throughput analytical tools and methods to characterize cell culture fluid during development and commercial cell culture processes
  • Unlocking the solute carrier gene-family for effective new therapies (unlock SLCs)
  • Patient perspectives in medicines lifecycle
  • Personalised medicine approaches in autism spectrum disorders


Deadline for submitting of short proposals is 28. March 2017 – 17:00:00 Brussels time.

Webinars about the IMI 2 - Call 10

Find partners for submitting a proposal via the Partner Search Tool
 

The Call text, as well as details of how to apply, can be found on the Call 10 web page.